news

An international team has described Foskeia pelendonum , a tiny Early Cretaceous ornithopod from Vegagete (Burgos, Spain), measuring barely half a meter long.

Not just milk, season or processing conditions, but also microbial dynamics in the factory and bacterial cultures determine the flavour of Gouda cheese.

An international research team led by Arne Van der Vreken, Eline Menu, and Karine Breckpot (Translational Oncology Research Center, VUB) has made an important discovery that may advance the fight against multiple myeloma, also known as Kahler's disease.

The news has been widely shared around the world: scientists have explored a 100-square-meter underground spider web - the largest known - housing no less than 110,000 spiders of two species which, strangely enough, cohabit without devouring each other. All the more reason to question our knowledge of the social behavior of spiders.

As language models learn to interpret words in a sentence, protein Language Models learn how amino acids work together within a protein Konstantina Tzavella, who used artificial intelligence in her r

Researchers at the ULB Center for Diabetes Research, in collaboration with Oxford University and the Broad Institute of MIT and Harvard, have mapped for the first time the effects of over 400 diabetes-related genetic variants on human pancreas cells. Their findings, published in Cell Genomics, open up new avenues for the development of personalized treatments.

A team led by Miriam Cnop (Faculty of Medicine, ULB Center for Diabetes Research and Erasmus Hospital) has just discovered a new type of diabetes in infants, linked to mutations in the TMEM167A gene. Published in the Journal of Clinical Investigation, this work carried out with the University of Exeter and international partners opens up new avenues for understanding the development of diabetes.

Thanks to a close collaboration between Carine Van Lint's laboratory (ULB), ULiège and UNamur, researchers have published their work in the international scientific journal PLOS Pathogens, focusing on a particular type of molecule produced by viruses - circular RNAs - and presenting an innovative bioinformatics tool capable of better identifying them.

What if there was a way to make ageing brain cells younger again? Researchers from Luxembourg and Spain recently set out to address this question. After developing an ageing clock capable of assessing the biological age of the brain, they used it to identify possible brain-rejuvenating interventions.

Amid the complexity of our decision-making, an opening remains for genuine human agency Does something like 'free will' really exist? We often take it for granted, but philosophers, psychologists and neuroscientists have debated the issue for decades - if not centuries. In his recent PhD at the Vrije Universiteit Brussel (VUB), titled The Free Will Discussion: an Interdisciplinary Analysis from the Psychological, Neuroscientific and Neurophilosophical Perspective , Eric Kerckhofs delves deeper into this fundamental question.

In a study published in Nature , biologists from the Université Libre de Bruxelles, Princeton and Rockefeller University reveal the molecular instructions that enable the cell to construct the nucleolus, the organelle essential for protein production. Better still, they have succeeded in manipulating this blueprint to produce, on demand, artificial nucleoli with modulated properties.

A study published in Science Advances reveals that sea turtles are fleeing the tropics, driven by climate change. They are heading dangerously towards the world's shipping lanes, with serious consequences for their conservation. An alarming study by Denis Fournier and Edouard Duquesne of the Université Libre de Bruxelles .

A study by researchers at the Interuniversity Institute of Bioinformatics in Brussels, the Structural Biology research group at Vrije Universiteit Brussel, and IBiTech-BioMMedA Group of Ghent University reveals how a key blood protein involved in inflammation and cancer -alpha-1-acid glycoprotein (AGP)-behaves in complex and surprising ways.

An international research team led by Professor Kiavash Movahedi from the Brussels Center for Immunology at the Vrije Universiteit Brussel has published groundbreaking results today in the prestigious journal Immunity . Their study sheds new light on the possibility of effectively replacing defective microglia-the brain's immune cells-marking a potential breakthrough in the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's.

At the LCSB, researchers model the complexity of the human brain in a Petri dish. Their work is highlighted in the latest episode of Primer , a new documentary series created by Bloomberg Originals that analyzes the complex science and technology shaping the future. Broadcast on March 27, the episode is entitled "Can Living Human Brain Cells Power AI?".

Researchers have identified a key gene in the regulation of nerve circuits in "Caenorhabditis elegans", a small worm often used in research. This gene, also present in humans, is associated with a rare form of infantile epilepsy. Their work suggests that an excessive release of neuropeptides could play a key role in this disease, opening up new research prospects.

On Rare Disease Day 2025, the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg illuminates once again its building in blue, green, pink, and purple, joining buildings across Luxembourg and around the world. This show of solidarity, organised in partnership with ALAN, the Luxembourg association for rare diseases , pays tribute to the 300 million people diagnosed worldwide with one of the more than 6000 known rare diseases, including 30,000 in Luxembourg.

February sees the start of alcohol-free month in Belgium. Alcohol dependence remains a major public health challenge, with high relapse rates despite treatment. Clémence Dousset, FNRS researcher at the Université libre de Bruxelles (ULB), explores neurofeedback: a complementary method that offers patients the chance to become actors in their own recovery by learning to regulate their brain activity.

Study uncovers the early immune responses that make insect venom immunotherapy the gold standard for curing severe allergies, offering hope for improving treatments worldwide. In a landmark clinical study just published in Nature Communications, researchers from the Luxembourg Institute of Health (LIH), the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, the Allergy Center Wiesbaden, Ulm University Hospital and Vrije Universiteit Brussels and UZ Brussel revealed the early immune mechanisms behind the exceptional success of insect venom immunotherapy.

KU Leuven team discovers that resistance to one antifungal medicine increases the efficacy of a different antifungal medicine Because Candida auris can easily develop resistance and because there is a limited range of antifungal medicine available, doctors are often faced with having exhausted all treatment options.